VivoSeq
Other

Knee Pain

0

Pipeline Programs↗

2

Active Trials↗

6

Companies Involved↗

Knee Pain is an early-stage landscape with 0 programs across 6 companies. The most active players are Jiangsu Aosaikang Pharmaceutical Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Olatec Therapeutics LLC.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

J

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

0 programs

PreclinicalH

Hisamitsu Pharmaceutical Co., Inc.

0 programs

PreclinicalO

Olatec Therapeutics LLC

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalN

Nektar Therapeutics

0 programs

PreclinicalEli Lilly logo

Eli Lilly

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed8 · 80%
Not yet recruiting1 · 10%
Active, not recruiting1 · 10%

Clinical Trials

Trial Activity

10 trials

Relationship Between Anterior Knee Pain and Patellar Tendon Elasticity After Infrapatellar Tendon-Split Tibial Intramedullary Nailing: A Prospective Cohort Study Using Shear-Wave Ultrasound Elastography
Active, not recruiting·BBagcilar Training and Research Hospital·N/A·NCT07659899·50 enrolled
The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain
Not yet recruiting·JJiangsu Aosaikang Pharmaceutical Co., Ltd.·Phase 1·NCT06614608·24 enrolled
Effect of Short-term Motor Training on Accuracy and Precision of Knee Movement in Human With and Without Knee Pain
Completed·—·N/A·NCT04146311·60 enrolled
Effect of Knee Pain on Walking Biomechanics
Completed·TThe Cleveland Clinic·Phase 4·NCT05670236·55 enrolled
HKT-500-US12 In Adult Patients With OA Knee Pain
Completed·HHisamitsu Pharmaceutical Co., Inc.·Phase 2·NCT00647231·300 enrolled
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Completed·OOlatec Therapeutics LLC·Phase 2·NCT02104050·202 enrolled
A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 1·NCT00772967·22 enrolled
A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain
Completed·NNektar Therapeutics·Phase 2·NCT01619839·296 enrolled
A Study of LY2828360 in Patients With Osteoarthritic Knee Pain
Completed·Eli Lilly logoEli Lilly·Phase 2·NCT01319929·39 enrolled
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
Completed·ZZetrOZ, Inc.·Phase 1/2·NCT05050448·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)